Advancements in plant transgenomics approach for the biopharmaceutics and vaccines production

Basit Öğe Kaydı
dc.authorscopusid57190065395
dc.authorscopusid14420615500
dc.authorscopusid58882228300
dc.authorscopusid16311550600
dc.authorscopusid7102666117
dc.contributor.authorKhan, Faria
dc.contributor.authorSzmigielski, Rafal
dc.contributor.authorGul, Alvina
dc.contributor.authorAltay, Volkan
dc.contributor.authorOzturk, Munir
dc.date.accessioned2024-09-19T15:43:47Z
dc.date.available2024-09-19T15:43:47Z
dc.date.issued2020
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractPlant transgenomics deals with the branch of omics whereby foreign gene insertion inside a plant genome can allow for the corresponding protein translation. The phenomena are now being widely employed in pharmaceuticals, drugs, and vaccine development by utilizing a plant gene construct and expression system. The current chapter highlights how the molecular farming strategy is employed at present to construct transgenic plants with a potential to express proteins with biopharmaceutical properties for drugs, antibodies, and vaccine production. It is also discussed how biopharmaceuticals and drug development can be revolutionized via plant transgenomics in the future. Plant transgenomics in biopharmaceuticals is already emerging as an independent field. Antibodies, therapeutic proteins, and bioactive products derived from transgenic plants are being researched at an extensive level. Vaccines derived from plants, particularly edible vaccines hold a great potential in mass-scale immunization programs. However, despite the progress in the field of plant transgenomics for drug development, a lot of research is imminent for efficacy, safety, and commercialization. Public acceptability for such biopharmaceutical products has to be taken into account before this developing field can ground its roots in the commercial settings. © 2020 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/B978-0-12-819541-3.00018-9
dc.identifier.endpage333en_US
dc.identifier.isbn978-012819541-3
dc.identifier.scopus2-s2.0-85131292442en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage317en_US
dc.identifier.urihttps://doi.org/10.1016/B978-0-12-819541-3.00018-9
dc.identifier.urihttps://hdl.handle.net/20.500.12483/14564
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofBiodiversity and Biomedicine: Our Futureen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBiopharmaceutical developmenten_US
dc.subjectMolecular farmingen_US
dc.subjectPlant transgenomicsen_US
dc.subjectPlant-derived biopharmaceuticalsen_US
dc.subjectPlant-derived vaccinesen_US
dc.titleAdvancements in plant transgenomics approach for the biopharmaceutics and vaccines productionen_US
dc.typeBook Chapteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full Text
Boyut:
780.73 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu